PORTLAND, Maine, March 19, 2026 /PRNewswire/ — The Council on International Educational Exchange (CIEE) today announced it is ...
2don MSN
High 5: Mass. student spends year in Malaysia as youth ambassador, gives back through teaching
A Concord-Carlisle High School senior who spent nearly a year studying halfway around the world is now using that experience ...
More than 80 prisoners used a single needle to inject illicit drugs in one day inside a Queensland jail, according to an alarming new study into substance use behind bars. One 42-year-old man told ...
The Hong Kong University of Science and Technology (HKUST), together with the other seven universities funded by the University Grants Committee ...
The dot plot delivered the bearish scenario on March 18. Silver fell. And the structural forces underneath the market didn’t ...
Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and ...
Alto Neuroscience secures $120M to advance novel depression therapy ALTO-207 through Phase 3 trials, aiming for FDA ...
New research from Peer39 shows signal poverty, not scale, is the core issue holding CTV back CTV's troubles came about ...
Partnership supports expanded biomarker discovery efforts within MJFF's Parkinson's Progression Markers Initiative. MORRISVILLE, N.C., March 17, 2026 /PRNewswire/ -- Metabolon, In ...
Perspectives of Young Europeans on China-Europe Relations," shows that 82 percent of young Europeans hold a positive view of ...
If you have not had a chance to review our quarterly earnings release, it can be found on our website at seraprognostics.com.
Liminatus today announced plans to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody designed to engage innate immune pathways and complement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results